Resveratrol: A supplementation for men or for mice?

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Ponzo, Valentina ^a   Soldati, Laura ^b   Bo, Simona ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Polyphenoles; Resveratrol; Wine

Indexed keywords

PIPERINE; QUERCETIN; RESVERATROL; SIRTUIN; STILBENE DERIVATIVE;

ARTICLE; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; CALORIC RESTRICTION; DIET; FOOD INTAKE; GLUCURONIDATION; GRAPE JUICE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; MOUSE; NONHUMAN; RED WINE; SULFATION; SUPPLEMENTATION; DIET SUPPLEMENTATION;

DIETARY SUPPLEMENTS; HUMANS; STILBENES;

EID: 84902120693     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-158     Document Type: Article

References (57)

1. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130:2073S-2085S.
2. Burns J, Yakota T, Ashihara H, Lean MEJ, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002, 50:3337-3340. 10.1021/jf0112973, 12010007.
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339:1523-1526. 10.1016/0140-6736(92)91277-F, 1351198.
4. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220. 10.1126/science.275.5297.218, 8985016.
5. Baur JA, Pearson KJ, Price NL. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342. 10.1038/nature05354, 17086191.
6. Howitz KT, Bitterman KJ, Cohen HT. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196. 10.1038/nature01960, 12939617.
7. Lagouge M, Argmann C, Gehart-Hines Z. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PRG-1. Cell 2006, 127:1-14.
8. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang HR, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang CH, Ungvari Z. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 2009, 297:H13-H20. 10.1152/ajpheart.00368.2009, 2711732, 19429820.
9. Kao CL, Chen LK, Chang YL, Yung MC, Hsu CC, Chen YC, Lo WL, Chen SJ, Ku HH, Hwang SJ. Resveratrol protects human endothelium from H2O2-induced oxidative stress and senescence via Sirt1 activation. J Atheroscler Thromb 2010, 17:970-979. 10.5551/jat.4333, 20644332.
10. Wang GL, Fu YC, Xu WC, Feng YQ, Fang SR, Zhou XH. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. Biochem Biophys Res Commun 2009, 380:644-649. 10.1016/j.bbrc.2009.01.163, 19285015.
11. Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 2007, 12:4839-4854. 10.2741/2432, 17569614.
12. Aziz MH, Kumar R, Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int J Oncol 2003, 23:17-28.
13. Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3_-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 2006, 5:1335-1341. 10.1158/1535-7163.MCT-05-0526, 16731767.
14. Reagan-Shaw S, Afaq F, Aziz MH, Ahmad N. Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 2004, 23:5151-5160. 10.1038/sj.onc.1207666, 15122319.
15. Lee HS, Ha AW, Kim WK. Effect of resveratrol on the metastasis of 4 T1 mouse breast cancer cells in vitro and in vivo. Nutr Res Pract 2012, 6:294-300. 10.4162/nrp.2012.6.4.294, 3439572, 22977682.
16. Atten MJ, Godoy-Romero E, Attar BM, Milson T, Zopel M, Holian O. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells. Invest New Drugs 2005, 23:111-119. 10.1007/s10637-005-5855-8, 15744586.
17. Huderson AC, Myers JN, Niaz MS, Washington MK, Ramesh A. Chemoprevention of benzo(a)pyrene-induced colon polyps in Apc(Min)mice by resveratrol. J Nutr Biochem 2012, 24:713-724. 3499643, 22889612.
18. Juan ME, Alfaras I, Planas JM. Colorectal cancer chemoprevention by trans-resveratrol. Pharmacol Res 2012, 65:584-591. 10.1016/j.phrs.2012.03.010, 22465196.
19. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 2010, 70:7392-7399. 10.1158/0008-5472.CAN-10-2027, 2948608, 20841478.
20. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007, 224:274-283. 10.1016/j.taap.2006.12.025, 2083123, 17306316.
21. Malhotra A, Nair P, Dhawan DK. Curcumin and resveratrol synergistically stimulate p21 and regulate cox-2 by maintaining adequate zinc levels during lung carcinogenesis. Eur J Cancer Prev 2011, 20:411-416. 10.1097/CEJ.0b013e3283481d71, 21633290.
22. Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, Brown K, Steward WP, Gescher AJ. Phase I randomized, doubleblind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases-safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res 2011, 4:1419-1425.
23. Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, Das DK, Delmas D, Gottfried C, Lin HY, Ma QY, Mukhopadhyay P, Nalini N, Pezzuto JM, Richard T, Shukla Y, Surh YJ, Szekeres T, Szkudelski T, Walle T, Wu JM. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 2011, 6:e19881. 10.1371/journal.pone.0019881, 3116821, 21698226.
24. Salado C, Olaso E, Gallot N, Valcarcel M, Egilegor E, Mendoza L, Vidal-Vanaclocha F. Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18. J Transl Med 2011, 9:59. 10.1186/1479-5876-9-59, 3112440, 21569399.
25. Wu JM, Hsieh TC. Resveratrol: a cardioprotective substance. Ann N Y Acad Sci 2011, 1215:16-21. 10.1111/j.1749-6632.2010.05854.x, 21261637.
26. Wang H, Yang YJ, Qian HY, Zhang Q, Xu H, Li JJ. Resveratrol in cardiovascular disease: what is known from current research?. Heart Fail Rev 2012, 17:437-448. 10.1007/s10741-011-9260-4, 21688187.
27. Tomé-Carneiro J, Larrosa M, González-Sarrías A, Tomás-Barberán FA, García-Conesa MT, Espín JC. Resveratrol and clinical trials: the crossroad fromin vitro studies to human evidence. Curr Pharm Des 2013, 19:6064-6093. 10.2174/13816128113199990407, 3782695, 23448440.
28. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNFinduced activation of nuclear transcription factors NF-B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000, 164:6509-6519. 10.4049/jimmunol.164.12.6509, 10843709.
29. Holmes MM, Baldwin ASJ. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IB kinase. Cancer Res 2000, 60:3477-3483.
30. Rocha KKR, Souza GA, Ebaid GX, Seiva FRF, Cataneo AC, Novelli ELB. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem Toxicol 2009, 47:1362-1367. 10.1016/j.fct.2009.03.010, 19298841.
31. Li Y, Cao Z, Zhu H. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 2006, 53:6-15. 10.1016/j.phrs.2005.08.002, 16169743.
32. Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2006, 290:E1339-1346. 10.1152/ajpendo.00487.2005, 16434553.
33. Palsamy P, Subramanian S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol 2010, 224:423-432. 10.1002/jcp.22138, 20333650.
34. Palsamy P, Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother 2008, 62:598-605.
35. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011, 14:612-622. 10.1016/j.cmet.2011.10.002, 3880862, 22055504.
36. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122. 10.1016/j.cell.2006.11.013, 17112576.
37. Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, Menon VP, Bagchi D, Maulik N. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signaling pathway in diabetic myocardium. J Cell Mol Med 2008, 12:2350-2361. 10.1111/j.1582-4934.2008.00251.x, 18266981.
38. Chi TC, Chen WP, Chi TL, Kuo TF, Lee SS, Cheng JT, Su MJ. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. Life Sci 2007, 80:1713-1720. 10.1016/j.lfs.2007.02.002, 17346750.
39. Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, Tomás-Barberán FA, García-Conesa MT, Espín JC. Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N Y Acad Sci 2013, 1290:37-51. 10.1111/nyas.12150, 23855464.
40. Sahebcar A. Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 2013, 71:822-835. 10.1111/nure.12081, 24111838.
41. Ghanim H, Sia CL, Abuaysheh S, Korzeniewski K, Patnaik P, Marumganti A, Chaudhuri A, Dandona P. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab 2010, 95:E1-E8. 10.1210/jc.2010-0482, 2936054, 20534755.
42. Bo S, Ciccone G, Castiglione A, Gambino R, De Michieli F, Villois P, Durazzo M, Cavallo-Perin P, Cassader M. Antiinflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers. Curr Med Chem 2012, 20:1323-1331.
43. Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, Møller N, Jessen N, Pedersen SB, Jørgensen JO. High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition. Diabetes 2012, 62:1186-1195. 3609591, 23193181.
44. Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Rossi Fanelli F, Patterson BW, Klein S. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 2012, 16:658-664. 10.1016/j.cmet.2012.09.015, 3496026, 23102619.
45. Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW, Barzilai N. Pilot Study of resveratrol in Older Adults With Impaired Glucose Tolerance. J Gerontol A Biol Sci Med Sci 2012, 67:1307-1312. 10.1093/gerona/glr235, 3670158, 22219517.
46. Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, Iwasaka T, Das DK. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res 2011, 31:842-847. 10.1016/j.nutres.2011.09.028, 22118755.
47. Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, Garcìa-Almagro FJ, Ruiz-Ros JA, Garcìa-Conesa MT, Tomàs-Barbéran FA, Espìn JC. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am J Cardiol 2012, 110:356-363. 10.1016/j.amjcard.2012.03.030, 22520621.
48. Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease. Clin Hemorheol Microcirc 2012, 50:179-187.
49. Heger A, Ferk F, Nersesyan A, Szekeres T, Kundi M, Wagner KH, Haidinger G, Misik M, Knasmuller S. Intake of a resveratrol- containing dietary supplement has no impact on DNA stability in healthy subjects. Mutat Res 2012, 749:82-86. 10.1016/j.mrgentox.2012.07.005, 22981768.
50. Militaru C, Donoiu I, Craciun A, Scorei ID, Bulearca AM, Scorei RI. Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life. Nutrition 2013, 29:178-183. 10.1016/j.nut.2012.07.006, 23153742.
51. Liu K, Zhou R, Wang B, Mi MT. Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr in press.
52. Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci 2011, 1215:9-15. 10.1111/j.1749-6632.2010.05842.x, 21261636.
53. de Santi C, Pietrabissa A, Mosca F, Pacifici GM. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 2000, 30:1047-1054. 10.1080/00498250010002487, 11197066.
54. De Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 2000, 30:609-617. 10.1080/004982500406435, 10923862.
55. Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, Ahmad N. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 2011, 55:1169-1176. 10.1002/mnfr.201100117, 3295233, 21714124.
56. Ortuño J, Covas MI, Farre M, Pujadas M, Fito M, Khymenets O, Andres- Lacueva C, Roset P, Joglar J, Lamuela-Raventos RM, de la Torre R. Matrix effects on the bioavailability of resveratrol in humans. Food Chem 2010, 4:1123-1130.
57. Scheepens A, Tan K, Paxton JW. Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes Nutr 2010, 5:75-87. 10.1007/s12263-009-0148-z, 2820202, 19841960.